Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Partial T-cell activation and anergy induction by polyclonal antithymocyte globulin

R M Merion1, T Howell, J S Bromberg

  • 1Department of Surgery, University of Michigan Medical School, Ann Arbor 48109, USA. merionb@umich.edu

Transplantation
|June 30, 1998
PubMed
Summary

Anti-human thymocyte globulin (ATGAM) induces immunosuppression by activating T cells, leading to anergy rather than depletion. This mechanism involves cross-linking multiple T cell receptors, resulting in reduced T cell proliferation and cytotoxicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validity of Online Versus In-Clinic Self-Reported Everyday Cognition Scale.

The journal of prevention of Alzheimer's disease·2022
Same author

Silk fibroin preserves beta cell function under inflammatory stress while stimulating islet cell surface GLUT2 expression.

Cellular immunology·2018
Same author

Intravenous immunoglobulin in drug and device refractory patients with the symptoms of gastroparesis-an open-label study.

Neurogastroenterology and motility·2017
Same author

Novel inhibition of PIM2 kinase has significant anti-tumor efficacy in multiple myeloma.

Leukemia·2016
Same author

Complications and Their Resolution in Recipients of Deceased and Living Donor Liver Transplants: Findings From the A2ALL Cohort Study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Comparison of the management and in-hospital outcomes of acute coronary syndrome patients in Australia and New Zealand: results from the binational SNAPSHOT acute coronary syndrome 2012 audit.

Internal medicine journal·2015

Area of Science:

  • Immunology
  • Transplantation Immunology

Background:

  • Polyclonal antithymocyte globulins are traditionally thought to deplete T cells.
  • This study investigates if anti-human thymocyte globulin (ATGAM) acts via non-depletive, immunologically specific mechanisms.

Purpose of the Study:

  • To test the hypothesis that ATGAM-mediated immunosuppression results from simultaneous engagement of multiple T cell receptors.
  • To elucidate the immunomodulatory effects of ATGAM on T cell function.

Main Methods:

  • Evaluated T cell proliferative responses and cell-mediated lympholysis in vitro and in vivo.
  • Used flow cytometry to assess ATGAM binding and receptor expression.
  • Measured cytokine levels (IL-2, IL-4) and ATGAM concentrations via ELISA.

Related Experiment Videos

Main Results:

  • ATGAM significantly inhibited T cell proliferation in a dose-dependent manner.
  • ATGAM-treated T cells showed reduced cytotoxicity and decreased IL-2 production.
  • Flow cytometry revealed ATGAM recognized multiple receptors, inducing partial T cell activation and anergy.

Conclusions:

  • ATGAM binds to and cross-links multiple T cell surface receptors and costimulator molecules.
  • This simultaneous engagement leads to partial T cell activation and anergy, contributing to immunosuppression.
  • The findings suggest a novel mechanism of ATGAM action beyond simple T cell depletion.